Search

everythinglearnresearchcommunity

for

Search:↓

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Immune therapy for cancer can cause hair loss scars in some patients.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

Poly(ADP-ribose) synthesis is linked to skin cell differentiation.

A man with a weakened immune system was diagnosed with a rare skin condition called trichodysplasia spinulosa using skin examination techniques.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

Animal models help study psoriasis but have limitations and don't fully mimic the human disease.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Alopecia areata may be treated by targeting immune system imbalances.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

The workshop aimed to improve hair loss disorder diagnosis and understanding.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Type I interferons play a key role in the development of various skin diseases.

Non-immune factors play a significant role in alopecia areata.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Mitochondrial stress can lead to atopic dermatitis.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.